These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 7318911

  • 21. Time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl-treated rat.
    Katovich MJ, Soltis EE, Iloeje E, Field FP.
    Pharmacology; 1984; 29(3):173-80. PubMed ID: 6091157
    [Abstract] [Full Text] [Related]

  • 22. Brain catecholamines in spontaneously hypertensive and DOCA-salt hypertensive rats.
    Fujino K.
    Acta Med Okayama; 1984 Aug; 38(4):325-40. PubMed ID: 6149670
    [Abstract] [Full Text] [Related]

  • 23. Contribution of salt to arterial wall changes in DOCA hypertension in the rat.
    Cox RH.
    J Hypertens; 1987 Oct; 5(5):611-9. PubMed ID: 3429865
    [Abstract] [Full Text] [Related]

  • 24. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T, Winternitz SR, Lindheimer MD, Oparil S.
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [Abstract] [Full Text] [Related]

  • 25. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM, Chen CC, Chang NC.
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [Abstract] [Full Text] [Related]

  • 26. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T, Sato Y.
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [Abstract] [Full Text] [Related]

  • 27. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y, Ando K, Fujita T.
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [Abstract] [Full Text] [Related]

  • 28. The role of chloride in the sympathetic nervous system in DOCA-salt hypertension.
    Motoyama T, Sano H, Miki T, Suzuki H, Kawaguchi K, Furuta Y, Fukuzaki H.
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):287-90. PubMed ID: 3390322
    [Abstract] [Full Text] [Related]

  • 29. Increased vasopressinergic activity following DOCA administration in the rat.
    Chen YF, Lindheimer MD, Oparil S.
    Brain Res Bull; 1986 Jan; 16(1):93-8. PubMed ID: 3955390
    [Abstract] [Full Text] [Related]

  • 30. Lithium prevents saline deoxycorticosterone acetate (DOCA) hypertension in the rat.
    Iaina A, Shochat J, Serban I, Kapuler S, Gavendo S, Goldfarb D, Eliahou HE.
    J Lab Clin Med; 1982 Feb; 99(2):231-8. PubMed ID: 6278037
    [Abstract] [Full Text] [Related]

  • 31. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    Nagahama S, Chen YF, Oparil S.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
    [Abstract] [Full Text] [Related]

  • 32. Central serotonergic alterations in deoxycorticosterone acetate/NaCl (DOCA/NaCl)-induced hypertension.
    Dawson R, Nagamhama S, Oparil S.
    Neuropharmacology; 1988 Apr; 27(4):417-26. PubMed ID: 3419540
    [Abstract] [Full Text] [Related]

  • 33. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
    Inoue A, Takahashi H, Lee LC, Sasaki S, Kohno Y, Takeda K, Yoshimura M, Nakagawa M.
    Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
    [Abstract] [Full Text] [Related]

  • 34. Influence of 19-nor-deoxycorticosterone on blood pressure, saline consumption, and serum electrolytes, corticosterone, and renin activity.
    Hall CE, Gomez-Sanchez CE, Holland OB, Nasseth D.
    Endocrinology; 1979 Sep; 105(3):600-4. PubMed ID: 157270
    [Abstract] [Full Text] [Related]

  • 35. Brain catecholamines during development of DOCA-salt hypertension in rats.
    Saavedra JM.
    Brain Res; 1979 Dec 21; 179(1):121-7. PubMed ID: 509225
    [Abstract] [Full Text] [Related]

  • 36. Enhanced induction of gastric carcinogenesis by N-methyl-N'-nitro-N-nitrosoguanidine in deoxycorticosterone acetate-NaCl hypertensive rats and its inhibition by potassium chloride.
    Tatsuta M, Iishi H, Baba M, Taniguchi H.
    Cancer Res; 1991 Jun 01; 51(11):2863-6. PubMed ID: 2032226
    [Abstract] [Full Text] [Related]

  • 37. Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension.
    Jeffries WB, McArdle S, Bockman C, Abel PW, Pettinger WA.
    Hypertension; 1991 Jan 01; 17(1):63-71. PubMed ID: 1846120
    [Abstract] [Full Text] [Related]

  • 38. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H, Kondo K, Saruta T.
    Acta Endocrinol (Copenh); 1981 Aug 01; 97(4):525-32. PubMed ID: 7270008
    [Abstract] [Full Text] [Related]

  • 39. Changes in vascular vasopressin receptors and responsiveness in DOCA/NaCl-treated rats.
    Smith CD, Pearlmutter F, Szkrybalo M, Katovich MJ.
    Clin Exp Hypertens A; 1988 Aug 01; 10(4):629-47. PubMed ID: 2968870
    [Abstract] [Full Text] [Related]

  • 40. Vasopressin-central nervous system interactions in the development of DOCA hypertension.
    Berecek KH, Barron KW, Webb RL, Brody MJ.
    Hypertension; 1982 Aug 01; 4(3 Pt 2):131-7. PubMed ID: 7068203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.